Technology Transfer

KKH is primarily a specialist Women’s and Children’s hospital that focuses on delivering quality of care for our population. As such, much of the research and innovation created evolve around these patient groups.

Technology Transfer & Research Further Development

Reach out to us here if you are keen to discuss license agreements or further development of our assets:

	Technology Transfer & Future Research Development	Target Patient Group
1	SpiroBooth - innovation to mitigate COVID‐19 risk in the lung function laboratory	Respiratory
2	iBreathezy – a device and method for measuring respiratory air flow	Respiratory
3	MetBot – an AI-driven calculator Chatbot for caregivers to manage Inborn Errors of Metabolism requiring protein restriction	Genetics, Dietetics

Assets Licensed to Commercial Entities